Suppr超能文献

相似文献

2
APASL consensus statements and management algorithms for hepatitis C virus infection.
Hepatol Int. 2012 Apr;6(2):409-35. doi: 10.1007/s12072-012-9342-y. Epub 2012 Mar 1.
3
APASL consensus statements and recommendation on treatment of hepatitis C.
Hepatol Int. 2016 Sep;10(5):702-26. doi: 10.1007/s12072-016-9717-6. Epub 2016 Apr 29.
4
APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.
Hepatol Int. 2016 Sep;10(5):681-701. doi: 10.1007/s12072-016-9736-3. Epub 2016 May 26.
5
Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).
Hepatol Int. 2009 Mar;3(1):269-82. doi: 10.1007/s12072-008-9106-x. Epub 2008 Nov 20.
6
Liver fibrosis: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL).
Hepatol Int. 2009 Jun;3(2):323-33. doi: 10.1007/s12072-008-9114-x. Epub 2008 Dec 4.
10
Consensus on extra-hepatic portal vein obstruction.
Liver Int. 2006 Jun;26(5):512-9. doi: 10.1111/j.1478-3231.2006.01269.x.

引用本文的文献

2
Pan-Immune-Inflammation Value as a Prognostic Biomarker for Hepatocellular Carcinoma Patients Undergoing Hepatectomy.
J Inflamm Res. 2025 May 20;18:6411-6425. doi: 10.2147/JIR.S521603. eCollection 2025.
5
Optimizing Hepatocellular Carcinoma Screening: A Comparative Simulated Abbreviated MRI Protocol Study.
Cureus. 2025 Feb 7;17(2):e78711. doi: 10.7759/cureus.78711. eCollection 2025 Feb.
7
Blood biomarkers of hepatocellular carcinoma: a critical review.
Front Cell Dev Biol. 2024 Nov 22;12:1489836. doi: 10.3389/fcell.2024.1489836. eCollection 2024.
9
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024.
Hepatol Int. 2024 Dec;18(6):1661-1683. doi: 10.1007/s12072-024-10732-z. Epub 2024 Nov 21.

本文引用的文献

1
Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review.
Hepatol Int. 2008 Mar;2(1):17-30. doi: 10.1007/s12072-007-9038-x. Epub 2007 Dec 29.
3
Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B.
J Hepatol. 2009 Jan;50(1):80-8. doi: 10.1016/j.jhep.2008.07.023. Epub 2008 Sep 21.
4
Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.
Gastroenterology. 2009 Jan;136(1):138-48. doi: 10.1053/j.gastro.2008.09.014. Epub 2008 Sep 18.
7
Molecular targeted therapies in hepatocellular carcinoma.
Hepatology. 2008 Oct;48(4):1312-27. doi: 10.1002/hep.22506.
10
Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma.
J Natl Cancer Inst. 2008 Aug 20;100(16):1134-43. doi: 10.1093/jnci/djn243. Epub 2008 Aug 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验